FERb 033
Identifiers | |
---|---|
IUPAC name
| |
CAS Number | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C13H9ClFNO3 |
Molar mass | 281.67 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
FERb 033 is a synthetic, nonsteroidal estrogen that was synthesized in 2009 and is used in scientific research.[1][2] It is a potent and selective ERβ agonist (Ki = 7.1 nM, EC50 = 4.8 nM), with 62-fold selectivity for the ERβ over the ERα.[1][2]
See also
References
- 1 2 Minutolo F, Bertini S, Granchi C, Marchitiello T, Prota G, Rapposelli S, Tuccinardi T, Martinelli A, Gunther JR, Carlson KE, Katzenellenbogen JA, Macchia M (2009). "Structural evolutions of salicylaldoximes as selective agonists for estrogen receptor beta". J. Med. Chem. 52 (3): 858–67. doi:10.1021/jm801458t. PMID 19128016.
- 1 2 Reese JM, Suman VJ, Subramaniam M, Wu X, Negron V, Gingery A, Pitel KS, Shah SS, Cunliffe HE, McCullough AE, Pockaj BA, Couch FJ, Olson JE, Reynolds C, Lingle WL, Spelsberg TC, Goetz MP, Ingle JN, Hawse JR (2014). "ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer". BMC Cancer. 14: 749. doi:10.1186/1471-2407-14-749. PMC 4196114. PMID 25288324.
External links
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.